Article

Prostate drug associated with iris prolapse, miosis

San Francisco—A drug commonly prescribed for older men suffering from prostate enlargement seems to cause a "floppy iris" that increases the risk of complications during cataract surgery.

Related Videos
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
AAO 2024: Matt Giegengack, MD: Injectable endothelial cell therapy shows promise for improving vision and reducing glare in corneal edema
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
Related Content
Emerging insights into ocular immune-related diseases and treatment options
January 1st 2025

Emerging insights into ocular immune-related diseases and treatment options

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Researchers awarded $2.7 million NIH grant to study retinal connections in RP
December 14th 2024

Researchers awarded $2.7 million NIH grant to study retinal connections in RP

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024

Study highlights current and potential roles of AI in glaucoma diagnosis

Early vision screening is key to slowing myopia progression in children
November 28th 2024

Early vision screening is key to slowing myopia progression in children

© 2025 MJH Life Sciences

All rights reserved.